Benign prostatic hyperplasia. Medical and minimally invasive treatment options.
Oesterling
J E
JE
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D018120:Finasteride / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000628:therapy; D015607:Stents
D000317:Adrenergic alpha-Antagonists; D018120:Finasteride; D010088:Oxidoreductases